scholarly article | Q13442814 |
P356 | DOI | 10.1055/S-2005-864121 |
P8608 | Fatcat ID | release_okb3o2jgyzeazmhzqracdwpcuu |
P698 | PubMed publication ID | 15902581 |
P2093 | author name string | Härtter S | |
Hiemke C | |||
Gilles M | |||
Heuser I | |||
Deuschle M | |||
Krumm B | |||
Shams M | |||
Kellner S | |||
P433 | issue | 3 | |
P304 | page(s) | 118-121 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Pharmacopsychiatry | Q15757383 |
P1476 | title | Paroxetine serum concentrations in depressed patients and response to treatment | |
P478 | volume | 38 |
Q48858316 | Association between plasma paroxetine concentration and changes in plasma brain‐derived neurotrophic factor levels in patients with major depressive disorder |
Q46052044 | Benefit of slow titration of paroxetine to treat depression in the elderly |
Q40946755 | Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems |
Q36079358 | Exposure-outcome analysis in depressed patients treated with paroxetine using population pharmacokinetics |
Q46101361 | Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder |
Q43415647 | Inverse correlation between clinical response to paroxetine and plasma drug concentration in patients with major depressive disorders |
Q48241646 | Outcome of treatment with antidepressants in patients with hypertension and undetected depression. |
Q37791156 | Pharmacogenomic implications of variants of monoaminergic-related genes in geriatric psychiatry |
Q39313611 | Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders |
Q45928085 | Rapid response to paroxetine is associated with plasma paroxetine levels at 4 but not 8 weeks of treatment, and is independent of serotonin transporter promoter polymorphism in Japanese depressed patients. |
Q36511678 | Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies |
Q36491587 | Serotonin transporter genotype interacts with paroxetine plasma levels to influence depression treatment response in geriatric patients |
Q33654737 | The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder |
Search more.